Append Medical
Trans-septal Left Atrial Appendage Closure Device
Company Overview
Snapshot
Founded in November 2016 by Zachi Berger, Append Medical operates with 11–50 employees. The company has raised $12.55 million across 3 funding rounds from 6 investors. In July 2023, Append Medical secured an initial closing of an extended Series A round.
Business overview
Append Medical is a Health Tech & Life Sciences company focused on developing a minimally invasive implantable device to reduce stroke risk in patients with atrial fibrillation. Its core technology is designed to achieve complete Left Atrial Appendage (LAA) closure, preventing blood clot leakage and mitigating device-related thromboembolism risk by minimizing foreign material at the closure site. The company operates in the medical devices sector, specifically within medical treatment and therapeutics, serving healthcare providers globally.
Strategic signal
In July 2023, Append Medical announced the initial closing of its extended Series A round, signaling continued investor confidence in its trans-septal. This funding indicates ongoing support for the company's development and potential market entry of its innovative solution for stroke prevention in atrial fibrillation patients, highlighting its immediate forward trajectory in advancing clinical trials and product commercialization.
Log in to access full profile ›Company Intelligence Q&A
- What is Append Medical's primary focus?
- Append Medical is focused on developing a minimally invasive implantable device for trans-septal Left Atrial Appendage (LAA) closure, aimed at reducing stroke risk in patients with atrial fibrillation.
- When was Append Medical founded?
- Append Medical was founded in November 2016.
- What was a significant recent funding event for Append Medical?
- In July 2023, Append Medical raised $4.35 million in the initial closing of an extended Series A round. Investors included Shoni Health Ventures and ALIVE Israel Healthtech Fund.
- Which investors participated in Append Medical's August 2021 Series A round?
- In August 2021, Append Medical completed a Series A round with participation from lead investor MedTecX and follow-on investor.
- What was the key development shared by Append Medical in February 2020?
- In February 2020, Append Medical shared clinical proof-of-concept results for the internal sealing of the Left Atrial Appendage.